New @NatureMedicine paper: A pan-cancer foundation model predicts immunotherapy response and highlights the biology behind it https://t.co/hfVQc24r6w @harvardmed news: https://t.co/1w6u8cEYBK Roughly a quarter of patients with advanced cancer respond durably to immune #CancerResearch #Immunotherapy #HealthTech #Nospecificcountrycodesfound.









